A. Cudolá

Acute and chronic HBV infection in central Argentina: High frequency of sub-genotype F1b, low detection of clinically relevant mutations and first evidence of HDV

M. B. Pisano, V. Ré, J. Debes, 2023, Frontiers in Medicine.

Prevalence of Rilpivirine Resistance in People Starting Antiretroviral Treatment in Argentina

H. Salomón, M. B. Bouzas, S. Giuliano, 2017, Antiviral therapy.

Pre-treatment drug resistance and HIV-1 subtypes in infants from Argentina with and without exposure to antiretroviral drugs for prevention of mother-to-child transmission

A. Mangano, R. Bologna, L. Sen, 2018, The Journal of antimicrobial chemotherapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

[Serological diagnosis of HTLV-1/2: combination of screening assays to define the serological status in blood donors].

M. G. Barbás, S. Gallego, C. Moreno, 2013, Revista Argentina de microbiologia.

Performance of a commercial assay for the diagnosis of influenza A (H1N1) infection in comparison to the Centers for Disease Control and Prevention protocol of real time RT-PCR.

E. Baumeister, S. Kademián, G. Castro, 2012, Revista Argentina de microbiologia.

[Screening of HIV in blood banks. Evaluation of fourth generation kits].

G. Barbás, S. Gallego, Elena Treviño, 2003, Medicina.

Retrospective study of the prevalence of human T‐cell lymphotropic virus‐type 1/2, HIV, and HBV in pregnant women in Argentina

A. Trenchi, S. Gallego, R. Gastaldello, 2007, Journal of medical virology.

Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014–15

H. Salomón, M. B. Bouzas, I. Zapiola, 2017, The Journal of antimicrobial chemotherapy.